FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to internal diseases, and can be used for prediction of risk of death in patients with chronic heart failure. Endogenous erythropoietin content in blood serum is determined by enzyme immunoassay. If the level is more than 16.19 mIU/ml, a high risk of death within a year is predicted.
EFFECT: method provides the possibility of improving the prediction of the unfavourable outcome in the patients with chronic heart failure by determining the content of endogenous erythropoietin in the blood serum by the enzyme immunoassay, which opens up possibilities for timely correction of therapy of these patients.
1 cl, 4 ex
